The Hormones in Dosage Except Contraceptives and Antibiotics market in Sweden showed a fluctuating trend from 2013, reaching its peak in 2014 at $61.27 before gradually declining to $35.5 by 2023. Between 2022 and 2023, a decline of 3.84% was noted, while the last five years saw a compound annual growth rate (CAGR) of -4.01%. The market's value per capita in 2023 stands at $35.5.
Future trends to watch for include:
- Potential stabilization or growth in demand as healthcare innovation improves hormone therapeutics.
- Monitoring demographic changes that could influence hormone therapy needs.
- Evaluating policy changes affecting healthcare funding for hormone treatments.
